Discover how compounding pharmacies are transforming healthcare by creating tailor-made medications for patients with unique needs, offering critical alternatives when standard drugs fall short, and ...

Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...

If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines ​unless they appear ...

Jaime Garcia injects five different peptides into her body that she gets from a doctor and a telemedicine company. The 44-year-old Los Angeles resident says the peptides have helped with myriad ...

– What are the resumes of top management? Are pharmacists leading the company? – Who is available for technical questions and how fast are they answered? – What are the qualifications of the staff and ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product ...

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a popular glucagon-like peptide 1 (GLP-1) weight loss and diabetes ...

While Congress debates the high cost of brand-name diabetes and weight loss drugs, Atlanta doctors are selling lower-cost alternatives made by compounding pharmacies. During a Senate committee hearing ...

SUGAR LAND, Texas, Jan. 6, 2026 /PRNewswire/ -- QuVa Pharma, Inc (Quva), a national, industry-leading provider of outsourced sterile injectable compounding services and health-system pharmacy data and ...